Treatment of movement disorders in dystonia-choreoathtosis cerebral palsy

Handbook of Clinical Neurology

Volumn 111, Issue , 2013, Pages 197-202

  Vidailhet, Marie ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84876800085     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-52891-9.00019-1     Document Type: Chapter

References (49)

1. Anderson W.S., Lawson H.C., Belzberg A.J., et al. Selective denervation of the levator scapulae muscle: an amendment to the Bertrand procedure for the treatment of spasmodic torticollis. J Neurosurg 2008, 108:757-763.
2. Angelini L., Broggi G., Nardocci N., et al. Subacute cervical myelopathy in a child with cerebral palsy. Secondary to torsion dystonia?. Childs Brain 1982, 9:354-357.
3. Anheim M., Vercueil L., Fraix V., et al. Early stimulation of DYT1 primary generalized dystonia prevents from its secondary irreversible complications. Mov Disord 2008, 23:2261-2263.
4. Ashwal S., Russman B.S., Blasco P.A., et al. Practice parameter: diagnostic assessment of the child with cerebral palsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2004, 62:851-863.
5. Azuma S., Seichi A., Ohnishi I., et al. Long-term results of operative treatment for cervical spondylotic myelopathy in patients with athetoid cerebral palsy: an over 10-year follow-up study. Spine 2002, 27:943-948. discussion 8.
6. Bax M.C., Flodmark O., Tydeman C. Definition and classification of cerebral palsy. From syndrome toward disease. Dev Med Child Neurol 2007, 39-41.
7. Burke R.E., Fahn S., Marsden C.D. Torsion dystonia: a double-blind, prospective trial of high-dosage trihexyphenidyl. Neurology 1986, 36:160-164.
8. Cif L., El Fertit H., Vayssiere N., et al. Treatment of dystonic syndromes by chronic electrical stimulation of the internal globus pallidus. J Neurosurg Sci 2003, 47:52-55.
9. Cif L., Vasques X., Gonzalez V., et al. Long-term follow-up of DYT1 dystonia patients treated by deep brain stimulation: an open-label study. Mov Disord 2010, 25:289-299.
10. Costa J., Espirito-Santo C., Borges A., et al. Botulinum toxin type A therapy for cervical dystonia. Cochrane Database Syst Rev 2005, (Online): CD003633.
11. Delgado M.R., Hirtz D., Aisen M., et al. Practice parameter: pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2010, 74:336-343.
12. Fuji T., Yonenobu K., Fujiwara K., et al. Cervical radiculopathy or myelopathy secondary to athetoid cerebral palsy. J Bone Joint Surg 1987, 69:815-821.
13. Group H.S. Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial. Neurology 2006, 66:366-372.
14. Guettard E., Roze E., Abada G., et al. Management of spasticity and dystonia in children with acquired brain injury with rehabilitation and botulinum toxin A. Dev Neurorehabil 2009, 12:128-138.
15. Hirose G., Kadoya S. Cervical spondylotic radiculo-myelopathy in patients with athetoid-dystonic cerebral palsy: clinical evaluation and surgical treatment. J Neurol Neurosurg Psychiatry 1984, 47:775-780.
16. Hoare B.J., Wallen M.A., Imms C., et al. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE). Cochrane Database Syst Rev 2010, (Online): CD003469.
17. Hoon A.H., Freese P.O., Reinhardt E.M., et al. Age-dependent effects of trihexyphenidyl in extrapyramidal cerebral palsy. Pediatr Neurol 2001, 25:55-58.
18. Jameson R., Rech C., Garreau de Loubresse C. Cervical myelopathy in athetoid and dystonic cerebral palsy: retrospective study and literature review. Eur Spine J 2010, 19:706-712.
19. Jan M.M. Misdiagnoses in children with dopa-responsive dystonia. Pediatr Neurol 2004, 31:298-303.
20. Jankovic J. Treatment of hyperkinetic movement disorders with tetrabenazine: a double-blind crossover study. Ann Neurol 1982, 11:41-47.
21. Jankovic J. Treatment of dystonia. Lancet Neurol 2006, 5:864-872.
22. Jankovic J. Treatment of hyperkinetic movement disorders. Lancet Neurol 2009, 8:844-856.
23. Jankovic J., Beach J. Long-term effects of tetrabenazine in hyperkinetic movement disorders. Neurology 1997, 48:358-362.
24. Kanekar S. Atlantoaxial dislocation in idiopathic cervical dystonia. Neurol India 2004, 52:124-125.
25. Koog Y.H., Min B.I. Effects of botulinum toxin A on calf muscles in children with cerebral palsy: a systematic review. Clin Rehabil 2010, 24:685-700.
26. Krach L.E. Intrathecal baclofen use in adults with cerebral palsy. Dev Med Child Neurol 2009, 51:106-112.
27. Krauss J.K., Loher T.J., Pohle T., et al. Pallidal deep brain stimulation in patients with cervical dystonia and severe cervical dyskinesias with cervical myelopathy. J Neurol Neurosurg Psychiatry 2002, 72:249-256.
28. Kupsch A., Benecke R., Muller J., et al. Pallidal deep-brain stimulation in primary generalized or segmental dystonia. N Engl J Med 2006, 355:1978-1990.
29. Lukban M.B., Rosales R.L., Dressler D. Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence. J Neural Transm 2009, 116:319-331.
30. Motta F., Buonaguro V., Stignani C. The use of intrathecal baclofen pump implants in children and adolescents: safety and complications in 200 consecutive cases. J Neurosurg 2007, 107:32-35.
31. Pollak L., Schiffer J., Klein C., et al. Neurosurgical intervention for cervical disk disease in dystonic cerebral palsy. Mov Disord 1998, 13:713-717.
32. Racette B.A., Lauryssen C., Perlmutter J.S. Preoperative treatment with botulinum toxin to facilitate cervical fusion in dystonic cerebral palsy. Report of two cases. J Neurosurg 1998, 88:328-330.
33. Rice J., Waugh M.C. Pilot study on trihexyphenidyl in the treatment of dystonia in children with cerebral palsy. J Child Neurol 2009, 24:176-182.
34. Russman B.S. Continuous intrathecal baclofen infusion for intractable spastic cerebral palsy - is it worth it?. Nat Clin Pract Neurol 2008, 4:476-477.
35. Sakzewski L., Ziviani J., Boyd R. Systematic review and meta-analysis of therapeutic management of upper-limb dysfunction in children with congenital hemiplegia. Pediatrics 2009, 123:e1111-e1122.
36. Sanger T.D., Bastian A., Brunstrom J., et al. Prospective open-label clinical trial of trihexyphenidyl in children with secondary dystonia due to cerebral palsy. J Child Neurol 2007, 22:530-537.
37. Schwarz C.S., Bressman S.B. Genetics and treatment of dystonia. Neurol Clin 2009, 27:697-718vi.
38. Shevell M.I., Dagenais L., Hall N. Comorbidities in cerebral palsy and their relationship to neurologic subtype and GMFCS level. Neurology 2009, 72:2090-2096.
39. Simpson D.M., Gracies J.M., Graham H.K., et al. Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2008, 70:1691-1698.
40. Steinbok P. Selective dorsal rhizotomy for spastic cerebral palsy: a review. Childs Nerv Syst 2007, 23:981-990.
41. Taira T., Hori T. Selective peripheral neurotomy and selective dorsal rhizotomy. Brain Nerve 2008, 60:1427-1436.
42. Taira T., Kobayashi T., Hori T. Selective peripheral denervation of the levator scapulae muscle for laterocollic cervical dystonia. J Clin Neurosci 2003, 10:449-452.
43. Tan E.K., Lo Y.L., Chan L.L., et al. Cervical disc prolapse with cord compression presenting with choreoathetosis and dystonia. Neurology 2002, 58:661-662.
44. Tarsy D. Comparison of clinical rating scales in treatment of cervical dystonia with botulinum toxin. Mov Disord 1997, 12:100-102.
45. Tarsy D., Simon D.K. Dystonia. N Engl J Med 2006, 355:818-829.
46. Vidailhet M., Vercueil L., Houeto J.L., et al. Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia. N Engl J Med 2005, 352:459-467.
47. Vidailhet M., Yelnik J., Lagrange C., et al. Bilateral pallidal deep brain stimulation for the treatment of patients with dystonia-choreoathetosis cerebral palsy: a prospective pilot study. Lancet Neurol 2009, 8:709-717.
48. Vles G.F., Hendriksen J.G., Visschers A., et al. Levetiracetam therapy for treatment of choreoathetosis in dyskinetic cerebral palsy. Dev Med Child Neurol 2009, 51:487-490.
49. Welter M.L., Grabli D., Vidailhet M. Deep brain stimulation for hyperkinetics disorders: dystonia, tardive dyskinesia, and tics. Curr Opin Neurol 2010, 23:420-425.